Microsoft Corp. sell BiotechBee
Start price
02.10.22
/
70%
€237.15
Target price
30.11.23
€200.00
Performance (%)
-3.35%
End price
21.12.22
€229.20
Summary
This prediction ended on 21.12.22 with a price of €229.20. With a performance of -3.35%, the SELL prediction for Microsoft Corp. by BiotechBee was down slightly. A total of €0.65 was paid as dividends for this prediction. BiotechBee has 70% into this predictionMicrosoft Corporation (MSFT) is a multinational technology company that develops and licenses software, services, and hardware products around the world. The company's operating segments are Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. Microsoft's popular products include Windows operating system, Microsoft Office software suite, LinkedIn social networking platform, Xbox gaming console, and Surface devices. Moreover, the company offers cloud-based services such as Azure, Office 365, and Dynamics 365. Microsoft has a reputation for generating strong cash flows and consistent dividend growth, with a broad customer base that includes both individual consumers and enterprise clients.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Microsoft Corp. | -0.920% | -0.920% | 49.794% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to BiotechBee what are the pros and cons of Microsoft Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Microsoft Corp. diskutieren
Sell mit Kursziel 200,0
In the thread Trading Microsoft Corp.
Stopped prediction by BiotechBee for Microsoft Corp.
Microsoft Corp.
Start price
Target price
Perf. (%)
€309.80
22.07.23
22.07.23
€400.00
31.05.26
31.05.26
10.83%
02.12.23
02.12.23
Could be very worthwhile Investment >20% year
